-
1
-
-
0035041926
-
-
1:CAS:528:DC%2BD3MXjvFCrsLk%3D 11346192
-
Allison 2001 J Clin Psychiatry 62 22 1:CAS:528:DC%2BD3MXjvFCrsLk%3D 11346192
-
(2001)
J Clin Psychiatry
, vol.62
, pp. 22
-
-
Allison1
-
2
-
-
0034819498
-
-
1:STN:280:DC%2BD3MvosV2nsQ%3D%3D 11526812
-
Coodin 2001 Can J Psychiatry 46 549 1:STN:280:DC%2BD3MvosV2nsQ%3D%3D 11526812
-
(2001)
Can J Psychiatry
, vol.46
, pp. 549
-
-
Coodin1
-
3
-
-
0034809696
-
Association of olanzapine-induced weight gain with an increase in body fat
-
DOI 10.1176/appi.ajp.158.10.1719
-
Eder 2001 Am J Psychiatry 158 1719 10.1176/appi.ajp.158.10.1719 1:STN:280:DC%2BD3MrjtF2nuw%3D%3D 11579009 (Pubitemid 32923669)
-
(2001)
American Journal of Psychiatry
, vol.158
, Issue.10
, pp. 1719-1722
-
-
Eder, U.1
Mangweth, B.2
Ebenbichler, C.3
Weiss, E.4
Hofer, A.5
Hummer, M.6
Kemmler, G.7
Lechleitner, M.8
Fleischhacker, W.W.9
-
4
-
-
7144256522
-
-
1:STN:280:DyaK1c3otlelug%3D%3D 9622049
-
Gupta 1998 Ann Clin Psychiatry 10 39 1:STN:280:DyaK1c3otlelug%3D%3D 9622049
-
(1998)
Ann Clin Psychiatry
, vol.10
, pp. 39
-
-
Gupta1
-
5
-
-
0034042934
-
Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study
-
DOI 10.1176/appi.ajp.157.6.975
-
Henderson 2000 Am J Psychiatry 157 975 10.1176/appi.ajp.157.6.975 1:STN:280:DC%2BD3c3pt1Omsg%3D%3D 10831479 (Pubitemid 30412350)
-
(2000)
American Journal of Psychiatry
, vol.157
, Issue.6
, pp. 975-981
-
-
Henderson, D.C.1
Cagliero, E.2
Gray, C.3
Nasrallah, R.A.4
Hayden, D.L.5
Schoenfeld, D.A.6
Goff, D.C.7
-
6
-
-
0028835191
-
-
10.1016/0924-977X(95)00012-E 1:CAS:528:DyaK2MXhtVSgsbvL 8998394
-
Hummer 1995 Eur Neuropsychopharmacol 5 437 10.1016/0924-977X(95)00012-E 1:CAS:528:DyaK2MXhtVSgsbvL 8998394
-
(1995)
Eur Neuropsychopharmacol
, vol.5
, pp. 437
-
-
Hummer1
-
7
-
-
64749101027
-
Weight effects associated with antipsychotics: A comprehensive database analysis
-
Parsons B, Allison DB, Loebel A et al (2009) Weight effects associated with antipsychotics: a comprehensive database analysis. Schizophr Res 110(1-3):103-110
-
(2009)
Schizophr Res
, vol.110
, Issue.1-3
, pp. 103-110
-
-
Parsons, B.1
Allison, D.B.2
Loebel, A.3
-
8
-
-
25144456112
-
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
-
DOI 10.1056/NEJMoa051688
-
Lieberman 2005 N Engl J Med 353 1209 10.1056/NEJMoa051688 1:CAS:528:DC%2BD2MXhtVeltL%2FN 16172203 (Pubitemid 41345943)
-
(2005)
New England Journal of Medicine
, vol.353
, Issue.12
, pp. 1209-1223
-
-
Lieberman, J.A.1
Scott Stroup, T.2
McEvoy, J.P.3
Swartz, M.S.4
Rosenheck, R.A.5
Perkins, D.O.6
Keefe, R.S.E.7
Davis, S.M.8
Davis, C.E.9
Lebowitz, B.D.10
Severe, J.11
Hsiao, J.K.12
-
9
-
-
0032751075
-
-
1:STN:280:DC%2BD3c%2FhvFWmug%3D%3D 10553730
-
Allison 1999 Am J Psychiatry 156 1686 1:STN:280:DC%2BD3c%2FhvFWmug%3D%3D 10553730
-
(1999)
Am J Psychiatry
, vol.156
, pp. 1686
-
-
Allison1
-
10
-
-
0035153224
-
-
10.2165/00002018-200124010-00005 1:CAS:528:DC%2BD3MXhsVWqsrY%3D 11219487
-
Wetterling 2001 Drug Saf 24 59 10.2165/00002018-200124010-00005 1:CAS:528:DC%2BD3MXhsVWqsrY%3D 11219487
-
(2001)
Drug Saf
, vol.24
, pp. 59
-
-
Wetterling1
-
11
-
-
1242337451
-
-
1:CAS:528:DC%2BD2cXitVyrsrg%3D 14750042
-
Cohen 2004 Pharmacopsychiatry 37 1 1:CAS:528:DC%2BD2cXitVyrsrg%3D 14750042
-
(2004)
Pharmacopsychiatry
, vol.37
, pp. 1
-
-
Cohen1
-
13
-
-
0842348094
-
Consensus development conference on antipsychotic drugs and obesity and diabetes
-
DOI 10.2337/diacare.27.2.596
-
American 2004 Diabetes Care 27 596 10.2337/diacare.27.2.596 (Pubitemid 38180442)
-
(2004)
Diabetes Care
, vol.27
, Issue.2
, pp. 596-601
-
-
Clark, N.G.1
-
15
-
-
0038014053
-
-
10.1038/sj.npp.1300027 1:CAS:528:DC%2BD3sXhslyjt7Y%3D 12629531
-
Kroeze 2003 Neuropsychopharmacology 28 519 10.1038/sj.npp.1300027 1:CAS:528:DC%2BD3sXhslyjt7Y%3D 12629531
-
(2003)
Neuropsychopharmacology
, vol.28
, pp. 519
-
-
Kroeze1
-
17
-
-
68849109515
-
-
10.4088/JCP.7075su1c.03 19570497
-
McElroy 2009 J Clin Psychiatry 70 12 10.4088/JCP.7075su1c.03 19570497
-
(2009)
J Clin Psychiatry
, vol.70
, pp. 12
-
-
McElroy1
-
18
-
-
34447341958
-
Metabolic side effects of antipsychotic medication
-
DOI 10.1111/j.1742-1241.2007.01416.x
-
Tschoner 2007 Int J Clin Pract 61 1356 10.1111/j.1742-1241.2007.01416.x 1:CAS:528:DC%2BD2sXpvFSnu7k%3D 17627711 (Pubitemid 47052363)
-
(2007)
International Journal of Clinical Practice
, vol.61
, Issue.8
, pp. 1356-1370
-
-
Tschoner, A.1
Engl, J.2
Laimer, M.3
Kaser, S.4
Rettenbacher, M.5
Fleischhacker, W.W.6
Patsch, J.R.7
Ebenbichler, C.F.8
-
21
-
-
44449103813
-
-
10.2337/dc07-1827 18071002
-
Rubin 2008 Diabetes Care 31 420 10.2337/dc07-1827 18071002
-
(2008)
Diabetes Care
, vol.31
, pp. 420
-
-
Rubin1
-
22
-
-
66149174932
-
-
10.1176/appi.ajp.2008.08071065 19339356
-
Andersohn 2009 Am J Psychiatry 166 591 10.1176/appi.ajp.2008.08071065 19339356
-
(2009)
Am J Psychiatry
, vol.166
, pp. 591
-
-
Andersohn1
-
23
-
-
4644354298
-
Lipid metabolism and insulin resistance in depressed patients: Significance of weight, hypercortisolism, and antidepressant treatment
-
DOI 10.1097/01.jcp.0000138762.23482.63
-
Kopf 2004 J Clin Psychopharmacol 24 527 10.1097/01.jcp.0000138762.23482. 63 1:CAS:528:DC%2BD2cXnt1Oqs78%3D 15349009 (Pubitemid 39274207)
-
(2004)
Journal of Clinical Psychopharmacology
, vol.24
, Issue.5
, pp. 527-531
-
-
Kopf, D.1
Westphal, S.2
Luley, C.W.3
Ritter, S.4
Gilles, M.5
Weber-Hamann, B.6
Lederbogen, F.7
Lehnert, H.8
Henn, F.A.9
Heuser, I.10
Deuschle, M.11
-
24
-
-
0030938705
-
-
1:CAS:528:DyaK2sXksVWlu7s%3D 9178335
-
Lustman 1997 Psychosom Med 59 241 1:CAS:528:DyaK2sXksVWlu7s%3D 9178335
-
(1997)
Psychosom Med
, vol.59
, pp. 241
-
-
Lustman1
-
26
-
-
0031018487
-
-
10.1038/sj.ijo.0800372 1:CAS:528:DyaK2sXhslWitbg%3D 9043962
-
Maheux 1997 Int J Obes Relat Metab Disord 21 97 10.1038/sj.ijo.0800372 1:CAS:528:DyaK2sXhslWitbg%3D 9043962
-
(1997)
Int J Obes Relat Metab Disord
, vol.21
, pp. 97
-
-
Maheux1
-
28
-
-
2942752141
-
-
10.1186/1471-2296-4-7
-
Paile-Hyvarinen 2003 BMC Fam Pract 14 7 10.1186/1471-2296-4-7
-
(2003)
BMC Fam Pract
, vol.14
, pp. 7
-
-
Paile-Hyvarinen1
-
29
-
-
34447337219
-
Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: A double-blind randomised placebo controlled 6-month trial
-
DOI 10.1186/1471-2296-8-34
-
Paile-Hyvarinen 2007 BMC Fam Pract 8 34 10.1186/1471-2296-8-34 17570858 (Pubitemid 47052765)
-
(2007)
BMC Family Practice
, vol.8
, pp. 34
-
-
Paile-Hyvarinen, M.1
Wahlbeck, K.2
Eriksson, J.G.3
-
30
-
-
0346014870
-
-
10.1176/appi.ajp.160.4.797 12668379
-
Fisfalen 2003 Am J Psychiatry 160 797 10.1176/appi.ajp.160.4.797 12668379
-
(2003)
Am J Psychiatry
, vol.160
, pp. 797
-
-
Fisfalen1
-
31
-
-
33645790328
-
-
10.4088/JCP.v67n0313 1:CAS:528:DC%2BD28Xkt1Kmsb4%3D 16649829
-
Laimer 2006 J Clin Psychiatry 67 421 10.4088/JCP.v67n0313 1:CAS:528:DC%2BD28Xkt1Kmsb4%3D 16649829
-
(2006)
J Clin Psychiatry
, vol.67
, pp. 421
-
-
Laimer1
-
32
-
-
0026794763
-
-
1:STN:280:DyaK38zmsFOntA%3D%3D 1298221
-
Mattson 1992 N Engl J Med 327 765 1:STN:280:DyaK38zmsFOntA%3D%3D 1298221
-
(1992)
N Engl J Med
, vol.327
, pp. 765
-
-
Mattson1
-
33
-
-
0028318560
-
-
10.1136/jnnp.57.6.682 1:STN:280:DyaK2c3nsFClug%3D%3D 8006647
-
Richens 1994 J Neurol Neurosurg Psychiatry 57 682 10.1136/jnnp.57.6.682 1:STN:280:DyaK2c3nsFClug%3D%3D 8006647
-
(1994)
J Neurol Neurosurg Psychiatry
, vol.57
, pp. 682
-
-
Richens1
-
34
-
-
0034086861
-
Weight gain associated with valproate in childhood
-
DOI 10.1016/S0887-8994(00)00133-8, PII S0887899400001338
-
Demir 2000 Pediatr Neurol 22 361 10.1016/S0887-8994(00)00133-8 1:STN:280:DC%2BD3cvgtVGjug%3D%3D 10913727 (Pubitemid 30410787)
-
(2000)
Pediatric Neurology
, vol.22
, Issue.5
, pp. 361-364
-
-
Demir, E.1
Aysun, S.2
-
35
-
-
0034864141
-
Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy
-
DOI 10.1046/j.1528-1157.2001.0420081002.x
-
Stephen 2001 Epilepsia 42 1002 10.1046/j.1528-1157.2001.0420081002.x 1:CAS:528:DC%2BD38Xht1Crt74%3D 11554885 (Pubitemid 32802064)
-
(2001)
Epilepsia
, vol.42
, Issue.8
, pp. 1002-1006
-
-
Stephen, L.J.1
Kwan, P.2
Shapiro, D.3
Dominiczak, M.4
Brodie, M.J.5
-
36
-
-
0034820072
-
Altered ovarian function and cardiovascular risk factors in valproate-treated women
-
DOI 10.1016/S0002-9343(01)00806-3, PII S0002934301008063
-
Isojarvi 2001 Am J Med 111 290 10.1016/S0002-9343(01)00806-3 1:CAS:528:DC%2BD3MXmvVKrtLc%3D 11566460 (Pubitemid 32885625)
-
(2001)
American Journal of Medicine
, vol.111
, Issue.4
, pp. 290-296
-
-
Isojarvi, J.I.T.1
Tauboll, E.2
Pakarinen, A.J.3
Van Parys, J.4
Rattya, J.5
Harbo, H.F.6
Dale, P.O.7
Fauser, B.C.J.M.8
Gjerstad, L.9
Koivunen, R.10
Knip, M.11
Tapanainen, J.S.12
-
37
-
-
43749104014
-
Pharmacological management of atypical antipsychotic-induced weight gain
-
DOI 10.2165/00023210-200822060-00003
-
Baptista 2008 CNS Drugs 22 477 10.2165/00023210-200822060-00003 1:CAS:528:DC%2BD1cXosVCrtb4%3D 18484791 (Pubitemid 351693690)
-
(2008)
CNS Drugs
, vol.22
, Issue.6
, pp. 477-495
-
-
Baptista, T.1
ElFakih, Y.2
Uzcategui, E.3
Sandia, I.4
Talamo, E.5
Araujo De Baptista, E.6
Beaulieu, S.7
-
39
-
-
0021349794
-
-
10.1055/s-2007-1014697 1:STN:280:DyaL2c7mtVSmsw%3D%3D 6368349
-
Micossi 1984 Horm Metab Res 16 59 10.1055/s-2007-1014697 1:STN:280:DyaL2c7mtVSmsw%3D%3D 6368349
-
(1984)
Horm Metab Res
, vol.16
, pp. 59
-
-
Micossi1
|